Sotorasib is now investigated in combination with panitumumab and FOLFIRI in the phase Ib CodeBreaK 101 study. 135 A total of 33 patients were treated with this combination with a median of two ...
Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial This open-label phase II study ...